101 related articles for article (PubMed ID: 19765446)
1. Vitamin D status, bone mineral density, and inflammation in kidney transplantation patients.
Sezer S; Yavuz D; Canoz MB; Ozdemir FN; Haberal M
Transplant Proc; 2009 Sep; 41(7):2823-5. PubMed ID: 19765446
[TBL] [Abstract][Full Text] [Related]
2. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
3. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
[TBL] [Abstract][Full Text] [Related]
4. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
Gutiérrez MJ; González E; Andrés A; Morales JM
Transplant Proc; 2009; 41(6):2348-50. PubMed ID: 19715916
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome.
Matteucci E; Carmellini M; Bertoni C; Boldrini E; Mosca F; Giampietro O
Ren Fail; 1998 Mar; 20(2):325-30. PubMed ID: 9574459
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
10. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients.
van Ree RM; Gross S; Zelle DM; van der Heide JJ; Schouten JP; van Son WJ; Gans RO; Bakker SJ
Transplantation; 2010 May; 89(10):1247-54. PubMed ID: 20559032
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
12. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients.
van Ree RM; Oterdoom LH; de Vries AP; Gansevoort RT; van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2007 Jan; 22(1):246-53. PubMed ID: 16998222
[TBL] [Abstract][Full Text] [Related]
14. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
16. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
Saha H
Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
[TBL] [Abstract][Full Text] [Related]
19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
20. Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis.
Mann ST; Stracke H; Lange U; Klör HU; Teichmann J
Metabolism; 2003 May; 52(5):579-85. PubMed ID: 12759887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]